targeted therapy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Bile Duct Cancer Market Eyes $3.89B by 2030 on Therapy Advances

Global bile duct cancer market projected to reach $3.89B by 2030 from $2.59B in 2025, driven by immunotherapy, AI diagnostics, and rising disease prevalence.
BMYCELGrABBVLLYAZN+1pharmaceutical innovationimmunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Esophageal Cancer Market Set to Surge 44% by 2030 as Big Pharma Races for Share

Esophageal cancer market projected to grow 44% to $2.37B by 2030 at 9.5% CAGR, with Pfizer, Roche, and Merck dominating through precision oncology and immunotherapy innovations.
BMYCELGrMRKPFENVS+2pharmaceutical innovationmarket growth